Zacks.com featured highlights include Hudbay Minerals, StoneCo, Centene and CVS Health

For Immediate ReleaseChicago, IL – July 3, 2025 – Stocks in this week’s article are Hudbay Minerals Inc. HBM, StoneCo Ltd. STNE, Centene Corp. CNC and CVS Health Corp. CVS.4 Value Stocks to Invest In for the 2nd Half of '25 Market ShiftThe Dow Jones Industrial Average stood out yesterday, climbing 0.91%, as market participants repositioned portfolios at the start of the second half of 2025. On the contrary, the S&P 500 and Nasdaq Composite edged lower, sliding 0.11% and 0.82%, respectively. Market sentiment remained cautious as investors assessed fresh policy signals from Fed Chair Jerome Powell and monitored developments surrounding President Donald Trump's mega bill. Given the current market scenario, it is prudent to shift focus toward value stocks.When evaluating value stocks, one of the most effective valuation metrics is the Price to Cash Flow (P/CF) ratio. Companies like Hudbay Minerals Inc., StoneCo Ltd., Centene Corp. and CVS Health Corp. boast a low P/CF ratio. The P/CF ratio evaluates the market price of a stock relative to the amount of cash flow that the company is generating on a per-share basis — the lower the number, the better.Price to Cash Flow Reflects Financial HealthValue investing is considered one of the best practices when it comes to picking stocks. It is essentially about selecting stocks that are fundamentally sound but have been beaten down by some external factors. Such stocks are poised to bounce back as and when investors recognize the inherent value of companies. Certainly, the value investment strategy best suits investors with a long-term horizon.There are different valuation metrics to determine a stock's inherent strength. Still, a random selection of a ratio cannot serve your purpose if you want a realistic assessment of a company's financial position. For this, the Price to Cash Flow ratio is one of the key metrics.Price-to-Cash-Flow metric evaluates the market price of a stock relative to the amount of cash flow that the company is generating on a per-share basis — the lower the number, the better. One of the important factors that makes P/CF a highly dependable metric is that operating cash flow adds back non-cash charges such as depreciation and amortization to net income, truly diagnosing a company's financial health.Analysts caution that a company's earnings are subject to accounting estimates and management manipulation. However, cash flow is reliable. Net cash flow unveils how much money a company is actually generating and how effectively management is deploying the same.Positive cash flow indicates an increase in a company's liquid assets. It gives the company the means to settle debt, meet its expenses, reinvest in its business, endure downturns and finally pay back its shareholders. Negative cash flow implies a decline in the company's liquidity, which in turn lowers its flexibility to support these moves.What's the Best Value Investing Strategy?An investment decision based solely on the P/CF metric may not yield the desired results. To identify stocks that are trading at a discount, you should expand your search criteria and also consider the price-to-book ratio, price-to-earnings ratio, and price-to-sales ratio. Adding a favorable Zacks Rank and a Value Score of A or B to your search criteria should lead to even better results as these eliminate the chance of falling into a value trap.Here are four of the 16 value stocks that qualified the screening:Hudbay Minerals, a copper-focused critical minerals company, sports a Zacks Rank #1. The company has a trailing four-quarter earnings surprise of 50%, on average. You can see the complete list of today's Zacks #1 Rank stocks here.The Zacks Consensus Estimate for Hudbay Minerals' current financial-year sales and earnings per share (EPS) suggests growth of 9.2% and 41.7%, respectively, from the year-ago period. HBM has a Value Score of A. Shares of HBM have risen 11.2% in the past year.Stone, a leading provider of financial technology and software solutions, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 6.4%, on average. (See the Zacks Earnings Calendar to stay ahead of market-making news.)The Zacks Consensus Estimate for Stone's current financial-year sales and EPS suggests growth of 10.9% and 6.7%, respectively, from the year-ago period. STNE has a Value Score of B. Shares of STNE have risen 33.3% in the past year.Centene, a leading healthcare enterprise, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 25.5%, on average.The Zacks Consensus Estimate for Centene's current financial year sales and EPS implies growth of 10.1% and 1.5%, respectively, from the year-ago period. Centene has a Value Score of A. Shares of Centene have declined 15.1% in the past year.CVS Health, a leading health solutions company, carries a Zacks Rank #2. The company has a trailing four-quarter earnings surprise of 18.1%, on average.The Zacks Consensus Estimate for CVS Health's current financial-year sales and EPS suggests growth of 3.5% and 12.9%, respectively, from the year-ago period. CVS Health has a Value Score of A. Shares of CVS have jumped 22.8% in the past year.You can get the rest of the stocks on this list by signing up now for your 2-week free trial to the Research Wizard and start using this screen in your own trading. Further, you can also create your own strategies and backtest them first before taking the investment plunge.The Research Wizard is a great place to begin. It's easy to use. Everything is in plain language. And it's very intuitive. Start your Research Wizard trial today. And the next time you read an economic report, open up the Research Wizard, plug your finds in, and see what gems come out.Click here to sign up for a free trial to the Research Wizard today.For the rest of this Screen of the Week article please visit Zacks.com at: https://www.zacks.com/stock/news/2560562/4-value-stocks-to-invest-in-for-the-second-half-2025-market-shiftDisclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.About Screen of the WeekZacks.com created the first and best screening system on the web earning the distinction as the "#1 site for screening stocks" by Money Magazine.  But powerful screening tools is just the start. That is why Zacks created the Screen of the Week to highlight profitable stock picking strategies that investors can actively use.Strong Stocks that Should Be in the NewsMany are little publicized and fly under the Wall Street radar. They're virtually unknown to the general public. Yet today's 220 Zacks Rank #1 "Strong Buys" were generated by the stock-picking system that has more than doubled the market from 1988 through 2016. Its average gain has been a stellar +25% per year. See these high-potential stocks free >>.Follow us on Twitter:  https://www.twitter.com/zacksresearchJoin us on Facebook:  https://www.facebook.com/ZacksInvestmentResearchZacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.Contact: Jim GiaquintoCompany: Zacks.comPhone: 312-265-9268Email: pr@zacks.comVisit: https://www.zacks.com/Zacks.com provides investment resources and informs you of these resources, which you may choose to use in making your own investment decisions. Zacks is providing information on this resource to you subject to the Zacks "Terms and Conditions of Service" disclaimer. www.zacks.com/disclaimer.Past performance is no guarantee of future results. Inherent in any investment is the potential for loss. This material is being provided for informational purposes only and nothing herein constitutes investment, legal, accounting or tax advice, or a recommendation to buy, sell or hold a security. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. It should not be assumed that any investments in securities, companies, sectors or markets identified and described were or will be profitable. All information is current as of the date of herein and is subject to change without notice. Any views or opinions expressed may not reflect those of the firm as a whole. Zacks Investment Research does not engage in investment banking, market making or asset management activities of any securities. These returns are from hypothetical portfolios consisting of stocks with Zacks Rank = 1 that were rebalanced monthly with zero transaction costs. These are not the returns of actual portfolios of stocks. The S&P 500 is an unmanaged index. Visit https://www.zacks.com/performancefor information about the performance numbers displayed in this press release.5 Stocks Set to DoubleEach was handpicked by a Zacks expert as the #1 favorite stock to gain +100% or more in the coming year. While not all picks can be winners, previous recommendations have soared +112%, +171%, +209% and +232%.Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.Today, See These 5 Potential Home Runs >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS): Free Stock Analysis Report HudBay Minerals Inc (HBM): Free Stock Analysis Report Centene Corporation (CNC): Free Stock Analysis Report StoneCo Ltd. (STNE): Free Stock Analysis ReportThis article originally published on Zacks Investment Research (zacks.com).Zacks Investment ResearchWeiter zum vollständigen Artikel bei Zacks Weiter zum vollständigen Artikel bei Zacks